TruBridge, Inc. (TBRG) स्टॉक विश्लेषण

कंपनी का अवलोकन

TruBridge, Inc. (TBRG) operates as a provider of specialized healthcare solutions and services designed to support community hospitals, clinics, and various healthcare systems across the United States and international markets. The company functions within the Healthcare sector, specifically targeting the Health Information Services industry, where it delivers critical infrastructure for revenue cycle management and patient care operations. Its operational scale is defined by a market capitalization of $262.96M, an annual revenue stream of $346.84M over the trailing twelve months, and an workforce comprising approximately 3,500 employees. These financial dimensions indicate that the company holds a mid-cap position in its sector, possessing significant revenue generation capabilities that are substantial relative to its market valuation, suggesting a mature business model focused on service delivery rather than rapid hyper-growth expansion.

वित्तीय स्वास्थ्य

The company generated a total revenue of $346.84M during the trailing twelve-month period, resulting in a net income of $4.21M and an EBITDA of $38.41M. The substantial disparity between the $346.84M revenue figure and the $4.21M net income reveals a cost structure characterized by high operating expenses, where the company retains only a minimal fraction of top-line revenue as bottom-line profit after covering all costs including taxes and interest. Despite the low net income, the business maintains strong operational cash generation with a free cash flow of $29.63M, which provides the entity with significant financial flexibility to fund operations, manage liquidity, or invest in technological infrastructure without relying heavily on external financing. Profitability analysis shows a gross margin of 53.0%, indicating efficient control over the cost of goods sold, while the operating margin sits at 2.0% and the profit margin at 1.3%, reflecting intense competitive pressures and high overhead costs typical in the health information services industry. On the balance sheet, the company holds $24.85M in cash against total debt of $166.74M, resulting in a leverage profile that is moderately aggressive with a debt-to-equity ratio of 93.70. Short-term liquidity is supported by a current ratio of 1.80, suggesting the firm has sufficient current assets to cover its current liabilities with a comfortable margin of safety. Furthermore, the return on equity stands at 2.5% and the return on assets is 3.9%, metrics that indicate that management's effectiveness in generating returns from shareholder capital and total assets is currently constrained by the low profit margins rather than operational inefficiency.

मूल्यांकन आकलन

The valuation metrics present a distinct dichotomy between historical and forward-looking expectations, with a trailing P/E ratio of 60.41 compared to a forward P/E of 5.98. This extreme difference implies that the market is pricing in a dramatic anticipated improvement in earnings trajectory, suggesting that current earnings are suppressed while future earnings are expected to expand significantly. The price-to-book ratio of 1.43 indicates that the stock trades at a moderate premium of roughly 43% over its net asset value, reflecting investor confidence in the company's intangible assets and service-based revenue model. Alternative valuation measures such as the price-to-sales ratio of 0.76 and an EV/EBITDA of 10.29 suggest the stock is priced reasonably relative to its sales volume and enterprise cash flow generation, offering a different perspective than the high multiple derived from low current earnings. In terms of trading range, the stock has a 52-week high of $27.15 and a 52-week low of $13.88, meaning the current price sits within this historical band but is notably closer to the upper end of the range relative to the low. The beta of 0.76 indicates that the stock's price volatility is lower than the broader market, suggesting it may act as a defensive position within a healthcare portfolio during periods of market turbulence.

Growth & Income

The growth profile for the trailing twelve months shows a revenue growth rate of 0.0% and an earnings growth rate listed as N/A, indicating a period of stabilization rather than expansion. With revenue growth stagnant, the absence of earnings growth data suggests that the company is currently operating at a steady state where operational improvements or cost efficiencies are being prioritized over top-line expansion. Regarding income distribution, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. This non-dividend strategy implies that the company retains all of its earnings to reinvest into business operations, technology upgrades, or debt reduction rather than returning capital directly to shareholders. Consequently, the overall growth and income profile for TruBridge, Inc. is characterized by a focus on capital retention and operational stability in the absence of recent revenue expansion or dividend payouts, positioning the firm to potentially capitalize on future market opportunities when conditions align.